Since DDX5 has been elucidated to have a well-defined mechanism of action in tumors including breast cancer by reviewing the literature, we established DDX5 as a reciprocal target and further examined whether AURKAIP1 fostered TNBC development via the DDX5 mediator. The gene discussed is AURKAIP1; the disease is breast carcinoma.